Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2015 1
2016 1
2019 2
2020 1
2021 1
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Polyamine-independent Expression of Caenorhabditis elegans Antizyme.
Stegehake D, Kurosinski MA, Schürmann S, Daniel J, Lüersen K, Liebau E. Stegehake D, et al. Among authors: kurosinski ma. J Biol Chem. 2015 Jul 17;290(29):18090-18101. doi: 10.1074/jbc.M115.644385. Epub 2015 Jun 1. J Biol Chem. 2015. PMID: 26032421 Free PMC article.
SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022.
Engels G, Oechsle AL, Schlegtendal A, Maier C, Holzwarth S, Streng A, Lange B, Karch A, Petersmann A, Streeck H, Blaschke-Steinbrecher S, Härtel C, Schroten H, von Kries R, Berner R, Liese J, Brinkmann F, Toepfner N; IMMUNEBRIDGE KIDS study group. Engels G, et al. Infection. 2023 Oct;51(5):1531-1539. doi: 10.1007/s15010-023-02052-5. Epub 2023 Jun 6. Infection. 2023. PMID: 37280412 Free PMC article.
Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project.
Lange B, Jaeger VK, Harries M, Rücker V, Streeck H, Blaschke S, Petersmann A, Toepfner N, Nauck M, Hassenstein MJ, Dreier M, von Holt I, Budde A, Bartz A, Ortmann J, Kurosinski MA, Berner R, Borsche M, Brandhorst G, Brinkmann M, Budde K, Deckena M, Engels G, Fenzlaff M, Härtel C, Hovardovska O, Katalinic A, Kehl K, Kohls M, Krüger S, Lieb W, Meyer-Schlinkmann KM, Pischon T, Rosenkranz D, Rübsamen N, Rupp J, Schäfer C, Schattschneider M, Schlegtendal A, Schlinkert S, Schmidbauer L, Schulze-Wundling K, Störk S, Tiemann C, Völzke H, Winter T, Klein C, Liese J, Brinkmann F, Ottensmeyer PF, Reese JP, Heuschmann P, Karch A. Lange B, et al. Among authors: kurosinski ma. Infection. 2024 Feb;52(1):139-153. doi: 10.1007/s15010-023-02071-2. Epub 2023 Aug 2. Infection. 2024. PMID: 37530919 Free PMC article.
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial.
Tiedje D, Borowski M, Simbrich A, Schlößler K, Kruse K, Bothe C, Kuss K, Adarkwah CC, Maisel P, Jendyk R, Kurosinski MA, Gerß J, Tschuschke C, Becker R, Roobol MJ, Bangma CH, Hense HW, Donner-Banzhoff N, Semjonow A. Tiedje D, et al. Among authors: kurosinski ma. Sci Rep. 2021 Dec 6;11(1):23503. doi: 10.1038/s41598-021-02696-z. Sci Rep. 2021. PMID: 34873188 Free PMC article. Clinical Trial.
Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial.
Semjonow A, Hense HW, Schlößler K, Simbrich A, Borowski M, Bothe C, Kruse K, Tiedje D, Kuss K, Adarkwah CC, Maisel P, Jendyk R, Kurosinski MA, Gerß J, Heidinger O, Tschuschke C, Becker R, Roobol MJ, Bangma C, Donner-Banzhoff N. Semjonow A, et al. Among authors: kurosinski ma. Eur Urol. 2019 Jul;76(1):1-3. doi: 10.1016/j.eururo.2019.01.008. Epub 2019 Jan 18. Eur Urol. 2019. PMID: 30665815
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
Harries M, Jaeger VK, Rodiah I, Hassenstein MJ, Ortmann J, Dreier M, von Holt I, Brinkmann M, Dulovic A, Gornyk D, Hovardovska O, Kuczewski C, Kurosinski MA, Schlotz M, Schneiderhan-Marra N, Strengert M, Krause G, Sester M, Klein F, Petersmann A, Karch A, Lange B. Harries M, et al. Among authors: kurosinski ma. Int J Infect Dis. 2024 Feb;139:50-58. doi: 10.1016/j.ijid.2023.11.014. Epub 2023 Nov 24. Int J Infect Dis. 2024. PMID: 38008353 Free article.
Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD).
Ajonina-Ekoti I, Ndjonka D, Tanyi MK, Wilbertz M, Younis AE, Boursou D, Kurosinski MA, Eberle R, Lüersen K, Perbandt M, Breloer M, Brattig NW, Liebau E. Ajonina-Ekoti I, et al. Among authors: kurosinski ma. Acta Trop. 2012 Oct;124(1):15-26. doi: 10.1016/j.actatropica.2012.05.013. Epub 2012 Jun 4. Acta Trop. 2012. PMID: 22677600
Comparative analysis of macrophage migration inhibitory factors (MIFs) from the parasitic nematode Onchocerca volvulus and the free-living nematode Caenorhabditis elegans.
Ajonina-Ekoti I, Kurosinski MA, Younis AE, Ndjonka D, Tanyi MK, Achukwi M, Eisenbarth A, Ajonina C, Lüersen K, Breloer M, Brattig NW, Liebau E. Ajonina-Ekoti I, et al. Among authors: kurosinski ma. Parasitol Res. 2013 Sep;112(9):3335-46. doi: 10.1007/s00436-013-3513-1. Epub 2013 Jul 3. Parasitol Res. 2013. PMID: 23820606
Corrigendum to "Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD)" [Acta Trop. 124 (2012) 15-26].
Ajonina-Ekoti I, Ndjonka D, Tanyi MK, Wilbertz M, Younis AE, Boursou D, Kurosinski MA, Eberle R, Lüersen K, Perbandt M, Breloer M, Brattig NW, Liebau E. Ajonina-Ekoti I, et al. Among authors: kurosinski ma. Acta Trop. 2016 Sep;161:114. doi: 10.1016/j.actatropica.2016.05.019. Epub 2016 Jun 20. Acta Trop. 2016. PMID: 27340046 No abstract available.
11 results